Kane Biotech Inc. (KNBIF)
Develops antimicrobial wound treatments and biofilm-fighting technologies for medical and personal care.
$0.02+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-37.6%
The outlook
KNBIF is trading near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage is thin, and the overall sentiment leans bearish based on current technical positioning. The stock remains deeply depressed relative to its recent highs.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range21% of the way from its 52-week low to high
Market cap
$3.7M
52-wk high
$0.04
52-wk low
$0.01
50-day avg
$0.02
200-day avg
$0.02
Trailing P/E
—